A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
Background: Malignant pleural mesothelioma (MPM) is a cancer with a high symptom burden and a median survival of less than one year. Evidence from other cancer types suggests there may be some benefit in health related quality of life (HRQoL) with the integration of early specialist palliative care...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Conference Paper |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/75022 |